Pharmaceutical manufacturer, one of America’s largest producers of prescription opioids, is in talks with its major investors about selling some or all of the company’s business units, potentially leading to its exit from the opioid business, according to people familiar with the discussions.Our Intelligence. Your Advantage.
Sign in or subscribe for access to peerless insight & analysis, curated data & interactives, and networking events.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
Bankrupt drugmaker Mallinckrodt considers sale of opioid businessBankrupt drugmaker Mallinckrodt considers sale of opioid business - WSJ
ادامه مطلب »
How this private prison healthcare company, facing lawsuits, went ‘bankrupt’The prison healthcare giant spun off into YesCare and Tehum. Now, it could pay pennies on the dollar for medical malpractice and civil rights claims.
ادامه مطلب »